Mr Matthew Gerard Winston Frohn

BRITISHUNITED KINGDOMBorn February 1967

Current Appointments
20

Longwall Ventures 4 Ecf (Gp) Llp

llp designated member · Since 18/02/2026

active
active
Longwall Ventures 4 Ecf (Fp) Llp

llp designated member · Since 13/02/2026

active
Momentum Bioscience Limited

director · Since 28/10/2019

Liquidation
Caristo Diagnostics Limited

director · Since 22/06/2018

Active
Longwall Ventures 3 Ecf (Nominee) Limited

director · Since 12/09/2017

Active
Longwall Ventures 3 Ecf (Gp) Llp

llp designated member · Since 11/09/2017

Active
Active
Longwall Ventures 3 Ecf (Fp) Llp

llp designated member · Since 07/09/2017

Active
Oxsonics Limited

director · Since 20/11/2013

Active
Oxford Technology Ecf (Gp) Member Limited

director · Since 29/11/2012

Active
Longwall Ventures Ecf (Gp) Member Limited

director · Since 09/11/2012

Active
Longwall Ventures Ecf (Gp) Llp

llp designated member · Since 08/10/2012

Active
Longwall Ventures Ecf (Fp) Llp

llp designated member · Since 08/10/2012

Active
Microvisk Ip Limited

director · Since 19/10/2011

Longwall Venture Partners Llp

llp designated member · Since 18/03/2011

Active
Crysalin Limited

director · Since 06/07/2010

Base4 Innovation Ltd

director · Since 16/12/2008

Oxford Technology Ecf (Gp) Llp

llp designated member · Since 09/12/2007

Active
Oxford Technology Ecf (Fp) Llp

llp designated member · Since 09/12/2007

Active

Summary

Current roles20
Former roles0
NationalityBRITISH
Based inUNITED KINGDOM
DOBBorn February 1967
Risk flags None detected

Financial FootprintActive cos.

Combined net worth£5.1m
Total employees46

Based on latest filed accounts for 5 of 20 active companies.

Data sourced from Companies House public register. Financial data from filed accounts. Updated as filings are processed.